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Neural stem cells (NSCs), when stimulated with epidermal
growth factor (EGF) or fibroblast growth factor-2 (FGF-2), have
the capacity to renew, expand, and produce precursors for
neurons, astrocytes, and oligodendrocytes. We postulated that
the early appearance of insulin-like growth factor (IGF-I) recep-
tors during mouse striatum development implies a role in NSC
regulation. Thus, we tested in vitro the action of IGF-I on the
proliferation of striatal NSCs. In the absence of IGF-I, neither
EGF nor FGF-2 was able to induce the proliferation of E14
mouse striatal cells. However, addition of IGF-I generated large
proliferative clusters, termed spheres, in a dose-dependent
manner. The newly generated spheres were multipotent, and
clonal analysis revealed that EGF or FGF-2, in the presence of
IGF-I, acted directly on NSCs. The actions of IGF-I suggest
distinct modes of action of EGF or FGF-2 on NSCs. First,
continuous versus delayed administration of these neurotrophic
factors showed that neither IGF-I nor EGF had an effect on NSC
survival, whereas FGF-2 promoted the survival or maintenance
of the stem cell state of 50% of NSCs for 6 d. Second, short-
term exposure to IGF-I induced the proliferation of NSCs in the
presence of EGF, but not of FGF-2, through an autocrine se-
cretion of IGF-I. These findings suggest that IGF-I is a key factor
in the regulation of NSC activation and that EGF and FGF-2
control striatal NSC proliferation, in part, through distinct intra-
cellular mechanisms.
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The in vitro study of neural stem cells (NSCs) (Reynolds et al.,
1992; Reynolds and Weiss, 1996; Palmer et al., 1997; Shihabuddin
et al., 1997) is a potent tool for delineating the actions of epige-
netic and intrinsic factors on precursors for neurons (Ahmed et
al., 1995; Johe et al., 1996; Arsenijevic and Weiss, 1998;
Shimazaki et al., 1999), astrocytes (Gross et al., 1996; Marmur et
al., 1998), and oligodendrocytes (Hammang et al., 1997; Ben-Hur
et al., 1998; Zhang et al., 1998). Recent in vitro studies of NSC-
based neurogenesis and gliogenesis suggest that these processes
occur by stepwise restriction and are dependent on environmen-
tal signals (Vescovi et al., 1993; DeHamer et al., 1994; Ahmed et
al., 1995; Kalyani et al., 1997; Mehler and Kessler, 1997; Palmer
et al., 1997; Rao and Mayer-Proschel, 1997; Arsenijevic and
Weiss, 1998). Control of NSC proliferation depends on the ac-
tions of epidermal growth factor (EGF) and/or its homolog
transforming growth factor-, basic fibroblast growth factor
(FGF-2), and the p75 receptor (Reynolds et al., 1992; Morshead
et al., 1994; Craig et al., 1996; Kalyani et al., 1997; Tropepe et al.,
1997, 1999). Moreover, several studies have shown that NSCs can
be isolated from different regions of the CNS during very early
development with FGF as the mitogen but not with EGF (Ka-
layani et al., 1999; Tropepe et al., 1999; Zhu et al., 1999; Qian et
al., 2000). NSCs become responsive to EGF at a later develop-
mental stage (Tropepe et al., 1999; Zhu et al., 1999). For cortical
progenitor cells, an increase in EGF receptors during develop-
ment appears to regulate the acquisition of EGF responsiveness
(Burrows et al., 1997; Lillien and Raphael, 2000), and this may be
modulated by different diffusible factors (Lillien and Raphael,
2000). For instance, in the presence of EGF, fewer cortical NSCs
could be generated from the cortex at embryonic day (E) 12 in
comparison to E15. And coculture of E15 cortical cells with E12
cells decreased the number of NSCs that could be generated from
E15 cells, suggesting that a diffusible factor at E12 prevented the
activation of NSCs (Lillien and Raphael, 2000). The inhibiting
factor was identified as the bone morphogenetic protein-4
(BMP4), which is present in the cortex during early development.
We hypothesized that other factors may be involved in the
control of NSC proliferation. The insulin-like growth factor-I
(IGF-I) receptor family is evolutionarily conserved from inverte-
brates to mammals, and IGF-I receptors are present throughout
the CNS during embryogenesis. IGF-II and IGF-I are expressed
during brain development and are believed to act on virtually all
neural cells (Petruzelli et al., 1986; Garofalo and Rosen, 1988;
LeRoith et al., 1988; Stylianopoulou et al., 1988; Bassas et al.,
1989; Bondy et al., 1990; Bartlett et al., 1991; Bondy, 1991;
Garcia-Segura et al., 1991; Devaskar et al., 1993; Kar et al., 1993).
The IGF-I receptors are expressed in germinal regions that co-
localize both EGF receptors and the FGF-receptor-1 (FGFR-1).
Considering that IGF family members play an important role in
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telencephalic development (de Pablo and de la Rosa, 1995), we
hypothesized a possible interaction between EGF, FGF-2, and
IGF-I on NSC regulation. Our results revealed that IGF-I is
necessary for the action of EGF and FGF-2 in inducing the
proliferation and expansion of striatal NSCs. In addition, we
found that EGF and FGF-2 have different modes of actions on
NSCs, including the transduction of intracellular signals.
MATERIALS AND METHODS
Primary culture and sphere passaging. Ganglionic eminences were re-
moved from 14-d-old BALB/c mouse embryos (IFFA Credo, L’Arbresle,
France) in PBS buffer containing 0.6% glucose, penicillin (50 U/ml), and
streptomycin (50 mg/ml) (both from Life Technologies, Paisley, Scot-
land). Tissue was mechanically dissociated with a fire-polished pipette in
serum-free medium composed of a 1:1 mixture of DMEM and F-12
nutrient (Life Technologies). Cells were grown in growth medium in
96-well plates (Falcon; Becton Dickinson, Franklin Lakes, NJ) at a
concentration of 5,000 cells per 200 l. The growth medium contained
DMEM and F-12 nutrient (1:1), glucose (0.6%), glutamine (2 mM),
sodium bicarbonate (3 mM), and HEPES buffer (5 mM), transferrin (100
mg/ml), progesterone (20 nM), putrescine (60 M), and selenium chloride
(30 nM) (all from Sigma, St. Louis, MO, except glutamine from Life
Technologies), and EGF or FGF-2 (20 ng/ml; PeproTech, Rocky Hill,
NJ). The number of spheres was counted after 8–10 d in vitro (DIV). Six
to eight wells per condition tested were counted.
Propagation of single spheres. Single spheres were evaluated for their
capacity to renew and expand. Individual spheres were transferred to 1.5
ml microtubes containing 200 l of the growth medium. Single spheres
were dissociated by mechanical action. Dissociated cells were then plated
in a 96-well plate and incubated for 10 DIV in the presence of various
growth factors.
Differentiation of spheres. After 8–10 DIV, the spheres were transferred
individually and plated onto poly-L-ornithine coated coverslips in 24-well
plates (Falcon; Becton Dickinson). Each well contained five spheres and
1 ml of the above-mentioned medium with insulin (25 g/ml) and 1%
fetal bovine serum (FBS), but no EGF or FGF-2. Spheres were fixed
after 7 DIV.
Antibodies. Primary antibodies for indirect immunocytochemistry in-
cluded (final dilution, source): mouse IgG monoclonal antibody to
-tubulin isotype III (1:1000; Sigma, Buchs, Switzerland), rabbit anti-
serum to GFAP (1:400; Dako, Glostrup, Denmark), mouse IgM mono-
clonal antibody to O4 (1:20; Roche Diagnostics, Rotkreuz, Switzerland).
Secondary antibodies (Jackson ImmunoResearch, West Grove, PA) were
as follows: cyanine-conjugated affinity-purified goat antibody to mouse
IgG (1:1000), fluorescein-conjugated affinity-purified goat antibody to
mouse IgG (1:100), and Coumarin (AMCA)-conjugated affinity-purified
goat antibody to mouse IgM (1:100).
Immunocytochemistry and cell counting. Indirect immunochemistry
using secondary antibodies conjugated to rhodamine, fluorescein, or
AMCA was performed on cells 7 d after plating as previously described
(Arsenijevic and Weiss, 1998). In brief, coverslips were fixed with 4%
paraformaldehyde for 20 min and washed three times successively with
PBS for 5 min each time. For triple-labeling experiments, primary
antibodies (anti--tubulin, 1:1000, and anti-GFAP, 1:400) were diluted in
PBS containing 10% normal goat serum and 0.3% Triton X-100. Cover-
slips were incubated for 2 hr at 37°C and then washed three times with
PBS as above. Cyanine- and fluorescein-conjugated secondary antibodies
to mouse and to goat IgG, respectively, were added. The cells were
incubated for 30 min at 37°C. After three 5 min PBS washes, slips were
incubated with IgM primary antibodies against O4 for 2 hr at 37°C. The
coverslips were washed again three times and incubated 30 min with
AMCA-conjugated secondary antibody to mouse IgM. Finally, the cells
were washed twice with PBS, and then Hoechst (1 mg/ml; Sigma) was
added for 15 min at room temperature, followed by two more PBS rinses
of 5 min each. A rapid water wash preceded the mounting on glass slides
with Fluorsave (Calbiochem, Darmstadt, Germany). Then, fluorescence
was detected and photographed with an Olympus BX40 photomicro-
scope (Olympus Optical, Tokyo, Japan).
Immunoreactive cells for -tubulin, GFAP, O4, or fluorescent nuclei
from Hoechst labeling were counted blind. Unpaired t tests were used to
distinguish differences between experiments, and paired t tests were used
to compare conditions within an experiment. All results are expressed as
a mean  SEM.
RESULTS
Neural stem cell proliferation stimulated by EGF or
FGF-2 requires the presence of IGF-I
Murine embryonic striatal NSCs can be isolated in vitro by in-
ducing their proliferation with either EGF (Reynolds et al., 1992)
or FGF-2 (Qian et al., 1997; Ciccolini and Svendsen, 1998;
Tropepe et al., 1999). The resulting proliferation generates a large
cell cluster that is termed a sphere or neurosphere. Each sphere
originates from one cell, and thus the presence of a sphere attests
to the presence of a stem cell (Reynolds and Weiss, 1996).
Primary germinal zone cells from the striatum (ganglionic emi-
nences) of the E14 mouse embryo were plated into single wells of
a 96-well plate in the presence of growth factors. The number of
spheres was then counted after 8–10 DIV. Thus, primary E14
striatal cells were plated at low density (see Material and Meth-
ods) in the presence of EGF or FGF-2 and increasing doses of
IGF-I. In the absence of IGF-I, no spheres were observed. How-
ever, IGF-I induced a dose-dependent increase in sphere number
with either EGF or FGF-2 (Fig. 1). The concentration at which
IGF-I is maximally effective, 3 nM, corresponded to the Kd of
the IGF-I receptor (LeRoith et al., 1993) and indicates that
physiological IGF-I concentrations are effective in promoting
sphere formation by EGF or FGF-2. However, it remained nec-
essary to establish and confirm that these spheres were generated
by NSCs. Because there are no markers available to unambigu-
ously distinguish NSCs from the other progeny generated in
Figure 1. Generation of striatal
spheres requires IGF-I. Primary striatal
E14 cells were plated at 5000 cells per
well in a 96-well plate in the presence of
EGF (A) or FGF-2 ( B) and increasing
concentrations of IGF-I. Eight to 10 d
later, the proliferating cells generating
“spheres” were counted. Six to eight wells
were analyzed per condition. The graphs
show a representative dose–response
curve of three wells for each group.
Note that in the absence of IGF-I, no
spheres were formed.
Arsenijevic et al. • Control of Striatal Stem Cell Proliferation J. Neurosci., September 15, 2001, 21(18):7194–7202 7195
spheres, we examined the NSC properties of the spheres. If NSCs
generate spheres and are further present in resultant spheres, one
dissociated sphere should produce at least one other sphere in the
original experimental conditions for NSC proliferation (renewal).
Also, the cells derived from these spheres should differentiate
into neurons, astrocytes, and oligodendrocytes (multipotential-
ity). To test the renewal capacity of the cells proliferating in the
presence of IGF-I and either EGF or FGF-2, spheres were
dissociated individually and plated in the same initial growth
medium. The data in Table 1 summarize a series of experiments
indicating that almost all EGF  IGF-I spheres were able to
generate at least one daughter sphere after dissociation. In me-
dium containing EGF  IGF-I, the primary spheres produced
2–435 secondary spheres. Moreover, the capacity to renew in
EGF  IGF-I was similar to conditions that were used previously
to test CNS stem cell self-renewal (high insulin concentration)
(Reynolds and Weiss, 1992, 1996; Reynolds et al., 1992) and
corresponded to 83% of the total spheres analyzed. Ninety per-
cent of FGF-2  IGF-I primary spheres were able to generate
secondary spheres (Table 1). No obvious differences between
EGF  IGF-I- and FGF-2  IGF-I-generated spheres were
observed.
From these experiments, IGF-I, together with EGF or FGF-2,
appeared to be sufficient to maintain NSC renewal. To determine
whether EGF  IGF-I and FGF-2  IGF-I spheres were multi-
potent, single spheres were transferred onto coverslips coated
with poly-L-ornithine in a medium containing 1–2% of FBS (no
EGF or FGF-2) to promote cell differentiation. After 7 DIV, the
spheres were fixed and stained by triple immunocytochemistry to
reveal neurons, astrocytes, and oligodendrocytes. In seven exper-
iments with EGF  IGF-I spheres, 64% of the 97 spheres exam-
ined were multipotent, and 94% contained neurons and astro-
cytes (Fig. 2, Table 1). Furthermore, 76% (68 of 89) of the FGF-2
 IGF-I spheres were multipotent (n  3), and 99% produced
neurons and astrocytes. Thus, IGF-I in the presence of EGF or
FGF-2 was necessary and sufficient to maintain self-renewal as
well as multipotentiality of striatal NSCs.
Because IGF-I receptors are ubiquitous, the action of IGF-I on
Table 1. EGF  IGF-I and FGF-2  IGF-I generated spheres are multipotent
Spheres
Proliferation Differentiation (spheres/total spheres)
Sphere Io (n) Renewing NAO NA A AO O
E  IGF-I 70 19 (29/33) 62/97 26/97 6/97 5/97 1/97
64% 27% 6% 5% 1%
E  IGF-I 24 hr 46  9.4 (29/33) 61/96 25/96 4/96 5/96 1/96
62% 26% 4% 5% 1%
F  IGF 56 6.3 (69/77) 68/89 20/89 1/89
76% 23% 1%
Single spheres were dissociated, and the cells were plated in 96-well plates in medium containing the growth factor used for the generation of primary spheres. Eight to 10
DIV later, newly generated spheres were counted (Sphere Io, mean  SEM). Sphere renewing indicates the number of spheres able to generate new spheres in comparison
to the total sphere number tested (n  4 experiments). Spheres generated in the presence of IGF-I and either EGF (n  7) or FGF-2 (n  3) were induced individually to
differentiate. IGF-I 24 hr indicates sphere generated with EGF and short-term exposure of IGF-I (n  6). Cells immunopositive for the neuronal marker -tubulin (N), the
astrocyte marker GFAP (A), and the oligodendroglial marker O4 (O) were recorded for each sphere. The cell identities in spheres are represented by the abbreviations N,
A, and O. The percentage of a specific sphere type in comparison to the whole population analyzed is indicated in each column. Sphere Io, primary source.
Figure 2. FGF-2  IGF-I and EGF  IGF-I
generated spheres are multipotent. Single
spheres were individually transferred to cul-
ture wells and exposed to conditions that favor
cell differentiation (see Materials and Meth-
ods). The majority of the analyzed spheres that
were generated by either FGF-2 (A–C) or EGF
(D–F ) (Table 1) contained cells immunoreac-
tive for the neuronal marker -tubulin (A, D,
arrows), the astrocyte marker GFAP (B, arrow-
head), and the oligodendrocyte marker O4 (F,
arrowhead). Magnification, 400.
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NSCs could be mediated by other cells via an unknown factor. To
verify a direct action of IGF-I on NSCs, striatal neural stem cell
proliferation was examined at clonal density. The cell numbers
ranged between 64 and 147 cells per well for experiments testing
the effect of IGF-I  EGF, and 20–29 cells per well for studies
with IGF-I  FGF-2. A total of 177,528 cells were analyzed from
three different experiments for EGF  IGF-I studies, and 16,338
cells were analyzed for FGF-2  IGF-I. In parallel experiments,
cells were plated at 5,000 cells per well. In all experiments, EGF
 IGF-I or FGF-2  IGF-I were able to generate spheres at
clonal density (Fig. 3, Table 2). For example, in one representa-
tive experiment, at a clonal density of 64  5 cells per well, 38
spheres were observed from a total of 18,432 cells plated in 288
wells. The growth rate was partially decreased (data not shown).
These experiments indicated that IGF-I and EGF or FGF-2 act
directly on NSCs.
FGF-2 promotes the survival or maintains the
undifferentiated state of NSCs, whereas EGF and IGF-I
do not
To begin to define the interactions and functions of IGF-I, EGF,
and FGF-2 in NSC proliferation and sphere formation, the puta-
tive survival action of each of these factors was tested. We define
survival to be a dependence on the presence of a factor through-
out the culture period. For example, if IGF-I is a survival factor
for NSCs, its constant presence, starting at plating time, should
allow for NSC proliferation regardless of when EGF is intro-
duced. Thus, IGF-I was added at plating and was present during
the entire cell culture period. Then, EGF was added either at
plating or at 3 or 5 DIV. Delayed administration of EGF was not
able to produce the same number of spheres generated when both
IGF-I and EGF were present starting at plating (Fig. 4B). The
loss of sphere number corresponds to 90%. The reverse exper-
iment, with the constant presence of EGF, similarly produced
only a small number of spheres when IGF-I was delayed and only
added at 3 or 5 DIV. This series of experiments showed that
IGF-I and EGF had weak, if any, survival actions on NSCs.
Another possibility is that NSCs differentiated with either IGF-I
or EGF alone. On the other hand, the constant presence of
FGF-2 starting at plating allowed sphere formation when IGF-I
was added at 4 or 6 DIV. Approximately 50% of striatal NSCs
survived and could still be induced to proliferate at later time
points, having been maintained in the sole presence of FGF-2
(Fig. 4C). These experiments suggest that a component of the
actions of FGF-2 is to promote the survival of NSCs or to
enhance the maintenance of their undifferentiated state.
FGF-2 and EGF likely act on the same striatal neural
stem cells
The fact that NSCs can be generated either by EGF  IGF-I
or by FGF-2  IGF-I leads us to consider whether these factors
act on the same cells, or on two separate populations. First, we
compared the number of spheres generated in the presence of
IGF-I  EGF, IGF-I  FGF-2, and IGF-I  EGF  FGF-2. If
two populations of NSCs exist, an additive action of EGF and
FGF-2 should occur. We found that the absolute number of
spheres generated in the presence of IGF-I  EGF was not
very different from the number generated with IGF-I  FGF-2
(Fig. 1). The co-incubation of the three factors (IGF-I, EGF,
FGF-2) produced a similar number of spheres to those gener-
ated by the stimulation of IGF-I  EGF or IGF-I  FGF-2
(n  5) (Fig. 5). These data suggest that EGF and FGF-2 likely
act on the same NSCs. To further test this, we hypothesized
that during the first 4 DIV, FGF-2 will allow the survival of
NSCs (as illustrated in Fig. 4) that should, in turn, be respon-
sive to the subsequent actions of EGF and IGF-I. This was
indeed the case, and the results are shown in Figure 5. When
NSCs were incubated in FGF-2 for 4 DIV, the cells were
washed, and EGF  IGF-I was added, the same number of
spheres was generated as was produced in the constant pres-
ence of FGF-2 and IGF-I.
Figure 3. Clonal analysis reveals a di-
rect action of IGF-I on NSCs. The effect
of EGF and IGF-I was tested with stri-
atal E14 cells that were plated at clonal
density (30–150 cells per 96-well plate).
Cells were followed continuously. Be-
tween 2 and 5 DIV, rare cells enlarged
(A) and divided (B) to form a sphere
(C) after 10–15 DIV. Similar observa-
tions were made for cells responsive to
IGF-I  FGF-2 (data not shown) (Ta-
ble 2). Magnification, 400.
Table 2. IGF-I  EGF or FGF-2 induces striatal cell proliferation at
clonal density
Experiment
number and
condition
Cell concentration
(cells/well)
Total number
of cells
plated
Sphere
number
1. E  I 103 39,552 75
2. E  I 147 119,544 163
3. E  I 64 18,432 38
4. F  I 26 6,838 15
5. F  I 20 3,816 8
6. F  I 29 5,684 4
E14 striatal cells were plated at clonal density in 96-well plates in the presence of
IGF-I and EGF or FGF-2. To determine cell concentration, all cells contained in a
well were counted after plating (8 wells per experiment were checked). For each
experiment, the total number of cells plated is given in the third column (for the first
experiment a total of 39,552 cells were plated in 384 wells at a density of 103 cells
per well). At 10 DIV, the total number of spheres was counted for the total of cells
plated. E, EGF; F, FGF-2; I, IGF-I.
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IGF-I stimulates its own secretion in the presence
of EGF
In previous studies, we found that IGF-I induced neuronal dif-
ferentiation (Arsenijevic and Weiss, 1998) and was able to do so
by the rapid (2–6 hr) activation of a genetic program mediated, in
part, by the transcription factor Brn-4 (Shimazaki et al., 1999). In
these studies, the very short exposure to IGF-I (2–24 hr) was
sufficient to allow for complete neuronal differentiation that con-
tinued for days after the removal of IGF-I. In line with such an
action, we hypothesized that a transient exposure to IGF-I may
also induce a program in NSCs that would permit mitogens to
activate proliferation. Thus, we examined the results of short-
term exposures to IGF-I on NSC proliferation. In the first series
of experiments, we found that IGF-I stimulation as short as 24 hr,
in the constant presence of EGF, was sufficient to produce a
sphere number comparable with those generated during a con-
tinuous co-incubation of IGF-I and EGF for 8 DIV (Fig. 6). On
the other hand, a 24 hr exposure to IGF-I did not support NSC
proliferation in the presence of FGF-2 (n  5), in comparison to
NSC coactivation for the entire period. The latter result demon-
strates a unique cooperative action of IGF-I with EGF and also
excludes an incomplete wash as explaining the success of transient
IGF-I with continuous EGF. Thus, the continuous presence of
IGF-I is not necessary for EGF-stimulated NSC proliferation,
and it is possible that an intracellular or transcription event
induced by the short exposure to IGF-I can maintain the prolif-
erative action of EGF. To confirm that a rapid induction may be
the case, we reduced IGF-I exposure time to a stimulation of 2 hr.
After only 2 hr of transient IGF-I exposure, 85% of NSCs could
be induced to proliferate in the continuous presence of EGF. In
parallel experiments, we found that the spheres generated by
short exposure to IGF-I and continuous EGF exhibited a virtually
identical pattern of renewal and multipotentiality (data not
shown) as seen with spheres that were generated in continuous
co-incubation (Table 1).
Figure 4. FGF-2 maintains in vitro the presence of embryonic striatal
NSCs. A, To test the possible survival effect of EGF or IGF-I on primary
E14 striatal cells, one factor was present during the whole experimental
period, whereas the other was administered 3–4 or 5–6 d after plating,
and the spheres were counted 8–10 DIV after the final addition. For cell
density conditions, see the legend to Figure 1. The co-incubation of EGF
 IGF-I beginning at plating served as control. B, All delayed adminis-
trations of EGF or IGF-I resulted in a significant decrease in sphere
number in comparison to the control group (B; n  5). C, The constant
presence of FGF-2 sustained NSC survival or the NSC state for at least 6
DIV (B; n  3–5). *p  0.05, **p  0.01, ***p  0.001, #p  0.2, in
comparison to the control group.
Figure 5. EGF and FGF-2 are both acting on the same stem cells. A, To
know whether IGF-I, EGF, and FGF-2 are acting on the same cells in our
culture conditions (5000 cells per well), the additive action of these factors
was tested. We have arbitrarily chosen IGF-I  FGF-2-generated sphere
number as the reference group. No significant differences were observed
between the groups. Note that no additive action of IGF-I, EGF, and
FGF-2 was observed (n  5). B, To confirm these results, the action of
FGF-2 on survival or the maintenance of the NSC state was assayed on
EGF-responsive stem cells. Substitution of FGF-2 by EGF  IGF-I at 4
DIV gave rise to a similar number of spheres in comparison to cells
stimulated by FGF-2 and IGF-I constantly (second column) or starting at
4 DIV (third column). Note that FGF-2 acts as a survival factor or
maintains NSC state for both FGF-2- and EGF-responsive stem cells. C,
Control culture without factors.
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These findings suggest that the synergistic actions of IGF-I and
EGF on NSCs involve a unique function or mechanisms. Such
actions were not apparent in the combined actions of IGF-I and
FGF-2 on NSCs. One potential mechanism for the sustained
action of IGF-I, after its transient exposure to NSCs, would be
through an EGF-dependent autocrine–paracrine release during
subsequent sphere formation. In fact, such an action underlies the
sustained action of transient IGF-I on neuronal differentiation
(Shimazaki et al., 1999). Thus, we added neutralizing antibodies
to IGF-I (Shimazaki et al., 1999) at the end of a 24 hr IGF-I
exposure and wash. During the subsequent continuous exposure
to EGF, we observed an 85 12.3% (n 4; p 0.0002) decrease
in sphere formation in comparison to the group incubated with
control IgG. These results indicate that IGF-I is endogenously
synthesized after a transient exposure to IGF-I and acts, in part,
to sustain continuous NSC proliferation by EGF. This observa-
tion further underscores, at the cellular level, the continued
physiological requirement of IGF-I for NSC proliferation.
DISCUSSION
The present work demonstrates that IGF-I is necessary for mouse
embryonic striatal NSC proliferation and that IGF-I acts syner-
gistically with EGF or FGF-2. It also appears that IGF-I, EGF,
and FGF-2 have distinct actions in the control of NSC state and
proliferation.
IGF-I is necessary for brain growth and neural stem
cell proliferation
Numerous studies revealed a pleiotropic action of IGF-I during
neurogenesis (de Pablo and de la Rosa, 1995; Ishii, 1995). How-
ever, no action of IGF-I on CNS stem cells has been reported.
Both during development and adulthood, IGF receptors and
ligands of IGF are present in the germinal zone as well as in the
subventricular zone (SVZ) (see the introductory remarks), sup-
porting the potential role of IGF-I in the in vivo regulation of
NSCs. In the present study, IGF-I was shown to regulate the
number of NSCs. If the number of proliferating NSCs depends on
IGF-I, it is reasonable to suggest that the final number of neural
cells should depend on the concentration of IGF family peptides
during brain development. This hypothesis is supported by brain
development in mice with null mutations of the IGFs or the IGF-I
receptor. All of these mutant mice have significant deficits in body
and brain development (Baker et al., 1993; Liu et al., 1993; Beck
et al., 1995). Our results show that IGF-I is necessary for the
activation of FGF-2-responsive NSCs, which can be isolated as
early as E8.5 (Tropepe et al., 1999). Studies of FGF-2 knock-out
mice revealed that FGF-2 is essential for normal brain develop-
ment (Deng et al., 1994; Yamaguchi et al., 1994) before the period
where IGF-I/II play an important role in brain–body develop-
ment (Baker et al., 1993; Liu et al., 1993). These results suggest
that FGF-2-responsive NSCs are likely controlled by another
factor besides IGF-I. Insulin is one good candidate, because its
secretion and subsequent biological action occurs throughout
embryonic development. However, during later embryonic devel-
opment, IGF-I seems to be of critical importance for brain for-
mation. A deficiency in IGF-I produces a delay of growth detect-
able at E13.5 (Baker et al., 1993), a time when EGF receptors play
a significant role in brain development, as attested by the mor-
phology of the CNS in EGF receptor-deficient mice (Sibilia et al.,
1998). During this period of CNS development, there is a striking
correlation between the temporal needs of both EGF and IGF-I.
Moreover, a more detailed analysis of IGF-I (/) mice showed
that the brain is reduced in size and that a specific population of
neurons is missing in the striatum (Beck et al., 1995); the latter
observation is in accordance with the role of IGF-I as a differ-
entiating factor on striatal neural precursors (Arsenijevic and
Weiss, 1998; Shimazaki et al., 1999).
The present IGF-I immunoneutralization study reveals that a
source of IGF-I may also be the NSC itself, revealing that IGF-I
is endogenously involved, at the cellular level, in the control of
NSC proliferation. An autocrine secretion occurs after co-
stimulation of EGF and IGF-I. These observations further sup-
port the tight link between EGF and IGF-I in the control of NSC
proliferation, as discussed above. EGF is present during the
period of development that sees dramatic increases in brain size.
From our study, it appears that EGF and IGF-I may participate in
a positive feedback loop for the expansion of NSCs. Such mech-
anisms may operate during the late brain growth phase to accel-
erate brain organogenesis. A negative control of IGF-I action
seems also to occur during this period of development and during
adulthood. Different types of IGF-I binding proteins (IGFBPs)
are known to enhance or inhibit IGF-I action depending on the
cellular context (Murphy, 1998). Studies of IGFBPs during brain
development (Bondy and Lee, 1993; Green et al., 1994) reveal
that IGFBP-5 may have a role related to NSCs. Messenger RNA
for IGFBP-5 is first detected at E10.5 in the neuroepithelium
(Green et al., 1994). High levels of IGFBP-5 mRNA persist in the
SVZ from postnatal day (P) 0 to at least P20 (Bondy and Lee,
1993). These results suggest that the action of IGF-I on stem cells
could be regulated by at least one member of the IGFBP family,
during the later stages of brain development as well as during
adulthood, thus enhancing the potential physiological role of
IGF-I on NSC regulation.
Mouse null mutation studies have revealed a dependence on
IGF-I, FGF-2, and EGF for brain growth, but have not demon-
strated specific functions for each of these growth factors. In the
Figure 6. Short exposure to IGF-I is sufficient to induce NSC prolifera-
tion in the presence of EGF, but not of FGF-2. Striatal cells from mouse
E14 embryos were stimulated with EGF for up to 10 DIV. During EGF
treatment, groups of cells received various time exposures of IGF-I: 10
DIV, 24 hr, or 2 hr. Only cells that were stimulated with IGF-I induced
sphere formation. No significant differences in sphere numbers were
observed between long- and short-term (24 and 2 hr) stimulation with
IGF-I (second and third columns, p  0.78). Short exposure of IGF-I
during the constant presence of FGF-2 rarely generated spheres (n  5;
**p  0.01).
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present study, FGF-2 clearly has an important action on NSC
survival or on the maintenance of the stem cell state. A survival
action of FGF-2 on PNS and CNS neurons has been demon-
strated (Unsicker et al., 1987; Walicke, 1988; Fontaine et al., 1998;
Krieglstein et al., 1998). Our results contrast with those of Drago
et al. (1991), who reported that IGF-I acted as a survival factor
for an FGF-2-responsive progenitor cell that gave rise to neurons
and glia. However, at the time of the latter study, the hierarchical
relationship between that progenitor cell and NSCs was not
clearly established, and thus the progenitor cell could be different
from the NSCs studied here. The progenitor cell described in the
Drago et al. (1991) study might be a more downstream–restricted
precursor cell, such as that described by Vescovi et al. (1993). An
alternative interpretation of our findings is that FGF-2 maintains
NSCs in an undifferentiated state. This would imply that, in the
absence of these growth factors NSCs differentiate to a nonpro-
liferative (sphere-forming) state. In this hypothesis, FGF-2 would
be the only factor that, in comparison to IGF-I or EGF, is able to
maintain NSC characteristics. Interestingly, in the absence of
exogenous growth factors that support proliferation, FGF-2 is
endogenously secreted by retinal stem cells to induce their pro-
liferation (Tropepe et al., 2000). It is not clear whether the lack of
FGF-2 induces cell death or differentiation of retinal stem cells.
Manipulation of IGF-I and FGF-2 in this system may allow
further light to be shed on the precise function of FGF-2.
Only with the addition of EGF could IGF-I support both
proliferation and survival of NSCs. Interestingly, FGF-2, EGF, or
IGF-I alone did not have a mitogenic action; rather a combination
was required to stimulate NSC proliferation. This is in contrast to
other biological systems in which, for example, either FGF-2 or
IGF-I alone can have an in vitro mitogenic action on C2C12
myoblasts (Milasincic et al., 1996), vascular smooth muscle cells
(Reape et al., 1996), and inner ear epithelial cells (Zheng et al.,
1997). In the latter two cases, combinations of the growth factors
have a synergistic effect on cell proliferation (Reape et al., 1996;
Zheng et al., 1997). Thus, the cooperative actions of IGF-I with
either EGF or FGF-2 in NSC proliferation is rather unique as
regards mitogenesis and may speak for the need for exquisite
control of this vital process. On the other hand, the precise role
for each factor in NSC cycle regulation remains to be determined.
One or two neural stem cells?
The existence of EGF- and FGF-2-responsive stem cells opens
the question of their lineage relationships. Several studies have
addressed whether two different NSCs exist or whether the tel-
encephalon contains one NSC that responds to the two different
growth factors (Ciccolini and Svendsen, 1998; Gritti et al., 1999;
Tropepe et al., 1999). The recent work by Tropepe et al. (1999)
revealed that at low cell culture density, EGF and FGF-2 have
additive actions on E14.5 NSCs, but this was not observed at high
cell culture density. These results suggest that two populations of
NSCs exists and that yet another factor controls NSC prolifera-
tion or survival. In contrast, studies either with B27 as an NSC
survival mixture (Ciccolini and Svendsen, 1998) or with adult
tissue (Gritti et al., 1999) suggest that a unique NSC is present in
the forebrain. The difference in methods between these studies
makes reconciling the data difficult. Our results suggest that
FGF-2 acts as a survival factor for a single population of E14
EGF- and FGF-2-responsive NSCs. In the study by Tropepe et al.
(1999), the influence of cell density on the generation of NSCs is
more significant for the actions of EGF than for those of FGF-2;
a high cell density allowed for a more elevated number of NSCs
after EGF stimulation. The evidence for two NSC populations
could be biased by the relative difference in survival actions of
FGF-2 and EGF. Thus, at low cell density, the survival of NSCs
is not optimum and the frequency of sphere formation depends
both on the mitogenic and the survival actions of the factors
tested. Ultimately, a thorough understanding of the factors that
regulate survival and/or proliferation of NSCs will be necessary
for reconciling whether there are single versus multiple NSC
populations in the forebrain.
EGF and FGF-2 have distinct actions on neural
stem cells
A principal conclusion derived from the present data is that EGF
and FGF-2 have distinct actions on striatal NSCs. These include
the control of survival or NSC state and the stimulation threshold
producing a biological action. As discussed above, FGF-2 has a
significant action on NSC survival or state. The fact that EGF
does not show this function indicates that the downstream effec-
tors of EGFR and the FGFR-1 are likely different, as regards the
control of the NSC state. A similar conclusion may be drawn
concerning the transduction pathway of EGFR compared with
that of FGFR-1 in relation to the activation of the IGF-I receptor.
Indeed, a short stimulation by IGF-I in the constant presence of
EGF was able to stimulate NSC proliferation, a biological effect
not observed with FGF-2. Together, it appears that NSCs possess
multiple levels of controls and distinct intracellular mechanisms
to regulate their state and proliferation. The actions of EGF and
FGF-2 are likely not fully redundant, but rather complementary
as well. Also, different intracellular pathways control the stimu-
lation of NSCs, presumably to integrate signals from various cell
environments. The regulation of NSC stimulation may be even
more complex. Indeed, for adult hippocampal NSCs, FGF-2 is
not sufficient even in the presence of IGF-I to control cell division
(Taupin et al., 2000). The glycosylated form of cystatin was found
to be necessary along with FGF-2 to activate the proliferation and
the expansion of adult hippocampal NSCs (Taupin et al., 2000).
Again, two cofactors were found necessary for this function. It
seems possible that different sets of cofactors regulate NSCs:
IGF-I and EGF on one hand, and FGF-2 and cystatin on the
other. It would be interesting to test whether these cofactor
requirements are inherent to NSCs of different regions and how
they are expressed during development and adulthood. Other
factors acting on embryonic or adult NSCs, such as TGF
(Tropepe et al., 1997), BMP4 and Noggin (Lillien and Raphael,
2000; Lim et al., 2000), as well as the ephrin family (Conover et
al., 2000) are also thought to act directly or indirectly on NSC
proliferation. Knowing when and where, during development and
adulthood, these factors are required and how they are effective
on the various NSCs of the CNS is of prime importance for
understanding NSC biology. Similarly, this knowledge is essential
for the optimization of in vivo mobilization of NSCs, when
attempting to produce the required cell phenotype in specific
brain regions as a strategy for neuronal replacement (Craig et al.,
1996; Kuhn et al., 1997; Aberg et al., 2000; Fallon et al., 2000).
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